368 related articles for article (PubMed ID: 19444933)
1. Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.
Clarke R; Shajahan AN; Riggins RB; Cho Y; Crawford A; Xuan J; Wang Y; Zwart A; Nehra R; Liu MC
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):8-20. PubMed ID: 19444933
[TBL] [Abstract][Full Text] [Related]
2. IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.
Ning Y; Riggins RB; Mulla JE; Chung H; Zwart A; Clarke R
Mol Cancer Ther; 2010 May; 9(5):1274-85. PubMed ID: 20457620
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate.
Schwartz-Roberts JL; Cook KL; Chen C; Shajahan-Haq AN; Axelrod M; Wärri A; Riggins RB; Jin L; Haddad BR; Kallakury BV; Baumann WT; Clarke R
Cancer Res; 2015 Mar; 75(6):1046-55. PubMed ID: 25576084
[TBL] [Abstract][Full Text] [Related]
4. BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.
Nehra R; Riggins RB; Shajahan AN; Zwart A; Crawford AC; Clarke R
FASEB J; 2010 Jun; 24(6):2040-55. PubMed ID: 20154269
[TBL] [Abstract][Full Text] [Related]
5. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
[TBL] [Abstract][Full Text] [Related]
6. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
7. Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.
Crawford AC; Riggins RB; Shajahan AN; Zwart A; Clarke R
PLoS One; 2010 Jan; 5(1):e8604. PubMed ID: 20062536
[TBL] [Abstract][Full Text] [Related]
8. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.
Gomez BP; Riggins RB; Shajahan AN; Klimach U; Wang A; Crawford AC; Zhu Y; Zwart A; Wang M; Clarke R
FASEB J; 2007 Dec; 21(14):4013-27. PubMed ID: 17660348
[TBL] [Abstract][Full Text] [Related]
9. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy.
Thomas S; Thurn KT; Biçaku E; Marchion DC; Münster PN
Breast Cancer Res Treat; 2011 Nov; 130(2):437-47. PubMed ID: 21298336
[TBL] [Abstract][Full Text] [Related]
10. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
11. BAG2 ameliorates endoplasmic reticulum stress-induced cell apoptosis in
Liang S; Wang F; Bao C; Han J; Guo Y; Liu F; Zhang Y
Autophagy; 2020 Aug; 16(8):1453-1467. PubMed ID: 31711362
[TBL] [Abstract][Full Text] [Related]
12. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
13. p65/RelA modulates BECN1 transcription and autophagy.
Copetti T; Bertoli C; Dalla E; Demarchi F; Schneider C
Mol Cell Biol; 2009 May; 29(10):2594-608. PubMed ID: 19289499
[TBL] [Abstract][Full Text] [Related]
14. SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells.
Liu H; Ma Y; He HW; Wang JP; Jiang JD; Shao RG
Autophagy; 2015; 11(12):2323-34. PubMed ID: 26218645
[TBL] [Abstract][Full Text] [Related]
15. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor.
Coser KR; Wittner BS; Rosenthal NF; Collins SC; Melas A; Smith SL; Mahoney CJ; Shioda K; Isselbacher KJ; Ramaswamy S; Shioda T
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14536-41. PubMed ID: 19706540
[TBL] [Abstract][Full Text] [Related]
17. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
[TBL] [Abstract][Full Text] [Related]
18. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
Rah B; ur Rasool R; Nayak D; Yousuf SK; Mukherjee D; Kumar LD; Goswami A
Autophagy; 2015; 11(2):314-31. PubMed ID: 25803782
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
[TBL] [Abstract][Full Text] [Related]
20. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]